Annual Operating Profit
-$108.47 M
+$6.93 M+6.01%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual operating income is -$108.47 million, with the most recent change of +$6.93 million (+6.01%) on December 31, 2022.
- During the last 3 years, EVLO annual operating profit has fallen by -$22.11 million (-25.60%).
- EVLO annual operating profit is now -732.75% below its all-time high of -$13.03 million, reached on December 31, 2016.
Performance
EVLO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$10.39 M
+$7.57 M+42.14%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly operating income is -$10.39 million, with the most recent change of +$7.57 million (+42.14%) on September 30, 2023.
- Over the past year, EVLO quarterly operating profit has increased by +$18.66 million (+64.24%).
- EVLO quarterly operating profit is now -99.50% below its all-time high of -$5.21 million, reached on March 31, 2017.
Performance
EVLO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$74.33 M
+$18.66 M+20.07%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM operating income is -$74.33 million, with the most recent change of +$18.66 million (+20.07%) on September 30, 2023.
- Over the past year, EVLO TTM operating profit has increased by +$40.60 million (+35.33%).
- EVLO TTM operating profit is now -1327.32% below its all-time high of -$5.21 million, reached on March 31, 2017.
Performance
EVLO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EVLO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.0% | +64.2% | +35.3% |
| 3 y3 years | -25.6% | +48.5% | +13.9% |
| 5 y5 years | -294.0% | +36.9% | +13.9% |
EVLO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.0% | at high | +64.9% | at high | +37.3% |
| 5 y | 5-year | -25.6% | +6.0% | at high | +68.2% | at high | +37.3% |
| alltime | all time | -732.8% | +6.0% | -99.5% | +68.2% | -1327.3% | +37.3% |
Evelo Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$10.39 M(-42.1%) | -$74.33 M(-20.1%) |
| Jun 2023 | - | -$17.96 M(-27.9%) | -$93.00 M(-11.1%) |
| Mar 2023 | - | -$24.90 M(+18.1%) | -$104.63 M(-3.5%) |
| Dec 2022 | -$108.47 M(-6.0%) | -$21.09 M(-27.4%) | -$108.47 M(-5.6%) |
| Sep 2022 | - | -$29.05 M(-1.8%) | -$114.94 M(-3.1%) |
| Jun 2022 | - | -$29.59 M(+3.0%) | -$118.59 M(+1.7%) |
| Mar 2022 | - | -$28.74 M(+4.3%) | -$116.66 M(+1.1%) |
| Dec 2021 | -$115.40 M(+25.6%) | -$27.56 M(-15.7%) | -$115.40 M(-0.6%) |
| Sep 2021 | - | -$32.71 M(+18.3%) | -$116.03 M(+12.1%) |
| Jun 2021 | - | -$27.66 M(+0.7%) | -$103.51 M(+7.7%) |
| Mar 2021 | - | -$27.47 M(-2.6%) | -$96.10 M(+4.6%) |
| Dec 2020 | -$91.89 M | -$28.20 M(+39.7%) | -$91.89 M(+6.4%) |
| Sep 2020 | - | -$20.18 M(-0.3%) | -$86.36 M(-1.5%) |
| Jun 2020 | - | -$20.25 M(-13.0%) | -$87.67 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$23.26 M(+2.6%) | -$88.81 M(+2.8%) |
| Dec 2019 | -$86.36 M(+48.6%) | -$22.67 M(+5.5%) | -$86.36 M(+8.4%) |
| Sep 2019 | - | -$21.50 M(+0.5%) | -$79.68 M(+6.8%) |
| Jun 2019 | - | -$21.39 M(+2.8%) | -$74.64 M(+9.0%) |
| Mar 2019 | - | -$20.80 M(+30.1%) | -$68.48 M(+17.9%) |
| Dec 2018 | -$58.10 M(+111.0%) | -$15.99 M(-2.8%) | -$58.10 M(+15.8%) |
| Sep 2018 | - | -$16.46 M(+8.1%) | -$50.18 M(+20.2%) |
| Jun 2018 | - | -$15.23 M(+46.1%) | -$41.76 M(+27.5%) |
| Mar 2018 | - | -$10.43 M(+29.2%) | -$32.75 M(+18.9%) |
| Dec 2017 | -$27.53 M(+111.4%) | -$8.07 M(+0.4%) | -$27.53 M(+41.4%) |
| Sep 2017 | - | -$8.04 M(+29.3%) | -$19.46 M(+70.3%) |
| Jun 2017 | - | -$6.22 M(+19.4%) | -$11.43 M(+119.4%) |
| Mar 2017 | - | -$5.21 M | -$5.21 M |
| Dec 2016 | -$13.03 M | - | - |
FAQ
- What is Evelo Biosciences annual operating income?
- What is the all time high annual operating profit for Evelo Biosciences?
- What is Evelo Biosciences annual operating profit year-on-year change?
- What is Evelo Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Evelo Biosciences?
- What is Evelo Biosciences quarterly operating profit year-on-year change?
- What is Evelo Biosciences TTM operating income?
- What is the all time high TTM operating profit for Evelo Biosciences?
- What is Evelo Biosciences TTM operating profit year-on-year change?
What is Evelo Biosciences annual operating income?
The current annual operating profit of EVLO is -$108.47 M
What is the all time high annual operating profit for Evelo Biosciences?
Evelo Biosciences all-time high annual operating income is -$13.03 M
What is Evelo Biosciences annual operating profit year-on-year change?
Over the past year, EVLO annual operating income has changed by +$6.93 M (+6.01%)
What is Evelo Biosciences quarterly operating income?
The current quarterly operating profit of EVLO is -$10.39 M
What is the all time high quarterly operating profit for Evelo Biosciences?
Evelo Biosciences all-time high quarterly operating income is -$5.21 M
What is Evelo Biosciences quarterly operating profit year-on-year change?
Over the past year, EVLO quarterly operating income has changed by +$18.66 M (+64.24%)
What is Evelo Biosciences TTM operating income?
The current TTM operating profit of EVLO is -$74.33 M
What is the all time high TTM operating profit for Evelo Biosciences?
Evelo Biosciences all-time high TTM operating income is -$5.21 M
What is Evelo Biosciences TTM operating profit year-on-year change?
Over the past year, EVLO TTM operating income has changed by +$40.60 M (+35.33%)